Symptoms and the Path of Progression
At a Glance
Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome (ADCA-DN) gradually affects coordination, hearing, and sleepiness, but symptoms can start in any order and progress differently. Care is tailored to changes in mobility, hearing, sleep, thinking, and nerve function.
While Autosomal Dominant Cerebellar Ataxia-Deafness-Narcolepsy Syndrome (ADCA-DN) is defined by its “core triad” of symptoms, the way the condition unfolds is unique to every person. Even within the same family, one person might experience hearing loss first, while another may struggle with sleepiness for years before any balance issues appear [1][2].
Understanding the typical patterns of progression can help you and your family prepare for changes and ensure you are receiving the right monitoring at each stage of the journey.
The Core Triad: A Detailed Look
The defining features of ADCA-DN involve three distinct systems of the body. These symptoms are progressive, meaning they tend to develop and worsen gradually over many years [1].
- Cerebellar Ataxia: This is a coordination disorder caused by the breakdown of cells in the cerebellum (the brain’s movement control center). It often begins as a subtle change in your walk (gait disturbance) or a feeling of “unsteadiness” [3]. Over time, you may notice shakiness (tremors) in your hands, difficulty with fine motor tasks like buttoning a shirt, or changes in your speech (dysarthria), which may sound slurred or slowed [2][4].
- Sensorineural Hearing Loss: This is a type of hearing loss caused by damage to the inner ear or the auditory nerve [5]. It typically affects both ears (bilateral) and usually worsens over time [1]. For some, this is the very first sign of the condition, sometimes appearing years before balance or sleep issues [2].
- Narcolepsy and Sleepiness: This feature often presents as hypersomnolence (extreme daytime sleepiness). You may feel an irresistible urge to sleep during the day or experience “sleep attacks” [6]. When a sleep specialist evaluates this, they look for clinical symptoms such as cataplexy (sudden muscle weakness triggered by emotion while remaining conscious) and use diagnostic tests like the Multiple Sleep Latency Test (MSLT) to check for markers like sleep-onset REM periods (SOREMPs) [6][2]. It is important to know that you may experience severe sleepiness without having clinical cataplexy, and your sleep tests may not always show classic SOREMPs immediately.
The Order of Symptoms: No Fixed Sequence
One of the most challenging aspects of ADCA-DN is its unpredictability. There is no “standard” order in which symptoms appear.
- Examples of Variable Onset: In some reported families, hearing loss and balance issues appear first, with sleepiness and cognitive changes developing years later [1]. In others, narcolepsy or extreme sleepiness is the very first sign, while ataxia and hearing loss do not emerge until much later [2][6].
- Variable Timeline: While most people begin experiencing symptoms in their 40s or 50s, exceptional cases have been reported in childhood [7]. Because of this variability, it is important not to compare your timeline too strictly to others, even relatives [8].
The Broader Spectrum of Symptoms
As ADCA-DN progresses, it can affect other parts of the nervous system and body. These findings have been reported in the broader spectrum of DNMT1-related disorders (including the related condition HSAN1E). Not every patient will experience these, and they are not inevitable:
- Cognitive and Psychiatric Changes: Some individuals experience executive dysfunction, which makes it harder to plan, organize, or focus on complex tasks [5]. In some cases, this can progress to more significant memory loss or dementia [2]. Psychiatric symptoms, including depression, anxiety, or more rarely psychosis (hallucinations or delusions), have also been reported in isolated cases or related spectrum disorders [5][9]. Note: Any sudden or severe psychiatric change requires urgent medical evaluation to rule out medication side effects, delirium, or other unrelated causes.
- Neuropathy: You may feel tingling, “pins and needles,” or numbness in your hands and feet. This is called peripheral neuropathy and occurs because the condition can damage the long nerves that travel to your limbs [10][3].
- Additional Rare Signs: Less commonly, patients on the DNMT1 spectrum may experience optic atrophy (wasting of the optic nerve), cataracts, seizures, or autonomic dysfunction (problems with automatic body functions like blood pressure) [9][10][3].
Looking Ahead: Progression and Monitoring
ADCA-DN is a life-altering condition, and its progressive nature means that your needs for support—such as hearing aids, mobility devices, or sleep medications—will likely increase over time [6][11].
Because ADCA-DN is so rare, reliable, general prognosis and survival data do not exist. Older studies on the related condition HSAN1E suggested specific life expectancy averages, but these should not be applied to ADCA-DN [10][5]. Every individual’s progression varies widely depending on their specific phenotype and complications [1].
Your medical team will focus on monitoring your specific symptoms. Tests are individualized and symptom-driven: neuropsychological testing may be used to establish a baseline, while repeated sleep studies (MSLTs) or MRIs are generally ordered only when a specific clinical question or major change in your condition warrants it [6][5].
Common questions in this guide
What symptoms make up the ADCA-DN core triad?
Do ADCA-DN symptoms always start in the same order?
At what age do ADCA-DN symptoms usually begin?
Can ADCA-DN affect memory, mood, or sensation?
How is ADCA-DN progression monitored?
What is the outlook for someone with ADCA-DN?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which symptom of the core triad appeared first in my case, and does that influence how we monitor for the others?
- 2.Can you perform or refer me for a formal neuropsychological evaluation to establish a baseline for my executive function and memory?
- 3.Since sleep markers can change over time, under what specific clinical circumstances should we repeat my sleep studies?
- 4.What signs of peripheral neuropathy or autonomic dysfunction should I be looking for at home?
- 5.Based on my current symptoms, what is the best way to balance physical therapy for ataxia with the fatigue caused by my sleepiness?
- 6.How should we coordinate care between my neurologist, sleep specialist, and audiologist to ensure my treatment plan is cohesive?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (11)
- 1
Identification of a methylation profile for DNMT1-associated autosomal dominant cerebellar ataxia, deafness, and narcolepsy.
Kernohan KD, Cigana Schenkel L, Huang L, et al.
Clinical epigenetics 2016; (8()):91 doi:10.1186/s13148-016-0254-x.
PMID: 27602171 - 2
Cerebellar Ataxia-deafness-narcolepsy (ADCA) syndrome. Description of a variable family phenotype.
Abenza-Abildúa MJ, Palmí-Cortés I, Ojeda-Ruiz de Luna J, et al.
Acta neurologica Belgica 2025; (125(5)):1395-1399 doi:10.1007/s13760-025-02776-1.
PMID: 40285998 - 3
Hummingbird sign in a patient with DNMT1-related disorder.
Tamura M, Sugiyama A, Hirano S, et al.
Neurocase 2025; (31(5)):239-244 doi:10.1080/13554794.2025.2560858.
PMID: 40937613 - 4
DNMT1-associated sensory neuropathy and cerebellar ataxia: A novel variant and review of genotype-phenotype correlation.
Menon PJ, Bogdanova-Mihaylova P, McDermott G, et al.
Journal of the peripheral nervous system : JPNS 2023; (28(3)):508-512 doi:10.1111/jns.12560.
PMID: 37199681 - 5
Autosomal dominant cerebellar ataxia, deafness, and narcolepsy (ADCA-DN) associated with progressive cognitive and behavioral deterioration.
Walker LA, Bourque P, Smith AM, Warman Chardon J
Neuropsychology 2017; (31(3)):292-303 doi:10.1037/neu0000322.
PMID: 27869457 - 6
Cataplexy and ataxia: red flags for the diagnosis of DNA methyltransferase 1 mutation.
Postiglione E, Antelmi E, Pizza F, et al.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2020; (16(1)):143-147 doi:10.5664/jcsm.8140.
PMID: 31957642 - 7
A novel DNMT1 mutation associated with early onset hereditary sensory and autonomic neuropathy, cataplexy, cerebellar atrophy, scleroderma, endocrinopathy, and common variable immune deficiency.
Fox R, Ealing J, Murphy H, et al.
Journal of the peripheral nervous system : JPNS 2016; (21(3)):150-3 doi:10.1111/jns.12178.
PMID: 27277422 - 8
Cerebellar Ataxia as a Common Clinical Presentation Associated with DNMT1 p.Y511H and a Review of the Literature.
Kikuchi JK, Nagashima Y, Mano T, et al.
Journal of molecular neuroscience : MN 2021; (71(9)):1796-1801 doi:10.1007/s12031-020-01784-5.
PMID: 33433851 - 9
Identification of a novel DNMT1 mutation in a Chinese patient with hereditary sensory and autonomic neuropathy type IE.
Zheng W, Yan Z, He R, et al.
BMC neurology 2018; (18(1)):174 doi:10.1186/s12883-018-1177-2.
PMID: 30342480 - 10
Defects of mutant DNMT1 are linked to a spectrum of neurological disorders.
Baets J, Duan X, Wu Y, et al.
Brain : a journal of neurology 2015; (138(Pt 4)):845-61 doi:10.1093/brain/awv010.
PMID: 25678562 - 11
Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches.
Velázquez-Pérez LC, Rodríguez-Labrada R, Fernandez-Ruiz J
Frontiers in neurology 2017; (8()):472 doi:10.3389/fneur.2017.00472.
PMID: 28955296
This page is for informational purposes only and does not constitute medical advice. It describes possible ADCA-DN symptom patterns; discuss new or worsening symptoms with your neurologist, sleep specialist, and audiologist.
Get notified when new evidence is published on Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.